|
|
News Breaks | | | | February 20, 2013 | | 11:05 EDT |  | OXBT | Oxygen Biotherapeutics announces tentative settlement of litigation
Oxygen Biotherapeutics announced that it has reached a tentative oral settlement of all litigation pending between the company and Tenor Opportunity Master Fund, Aria Opportunity Fund, and Parsoon Opportunity Fund. The litigation, filed by Tenor on August 30, 2011 in the United States District Court for the Southern District of New York, alleged that a right of first offer held by Tenor was breached in connection with the Company's June 2011 financing. The tentative agreement provides that the company will settle the matter for $600,000 in cash, payable in six quarterly installments commencing on the date the parties execute a written settlement agreement. The company admits no wrongdoing as part of the settlement. | |
|
News For OXBT From The Last 14 Days Check below for free stories on OXBT the last two weeks. |
|
|
| May 14, 2013 | | 12:00 EDT |  | OXBT | Oxygen Biotherapeutics falls 13.3%
 Subscribe for More Information | | | 10:00 EDT | | OXBT | Oxygen Biotherapeutics falls 11.5%
Oxygen Biotherapeutics is down 11.5%, or 60c, to $4.60 | | | May 10, 2013 | | 13:11 EDT | | OXBT | Oxygen Biotherapeutics announces reverse split effective after close on May 10
Subscribe for More Information | |
|
|
|
|
|
|
